New York, NY -- (SBWIRE) -- 01/10/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Synta Pharmaceuticals Corp (NASDAQ:SNTA), Solta Medical Inc (NASDAQ:SLTM), Ivanhoe Energy Inc. (USA) (NASDAQ:IVAN), VIVUS, Inc (NASDAQ:VVUS)
Synta Pharmaceuticals Corp (NASDAQ:SNTA) showed a volume of 1.39 million shares by the end of last trade whereas the average volume of the stock remained 1.77 million shares. The stock opened the session at $5.92 but then moved to $5.82. At that price, the stock showed a negative performance of -1.02%. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. As of December 31, 2011, it had two drug candidates in clinical trials for treating multiple types of cancer and several drug candidates in the preclinical-stage of development. Its drug candidates are discovered and developed internally,
Will SNTA Get Buyers Even After The Recent Rally? Find Out Here
Solta Medical Inc (NASDAQ:SLTM) opened the session at $2.92 and closed the session at $2.93. The stock showed a positive performance of 0.34% in previous trading session. Solta Medical, Inc. designs, develops, manufactures and markets professional and consumer energy-based medical device systems for aesthetic applications. The Company's systems are cleared by the United States Food and Drug Administration (FDA) for dermatological procedures performed in the physician led, professional assist, and personal care markets.
For How Long SLTM will fight for Profitability? Read This Trend Analysis report
Ivanhoe Energy Inc. (USA) (NASDAQ:IVAN) opened the session at $0.68 and closed the session at $0.599. The stock showed a negative performance of -11.87% in previous trading session. The beta of the stock remained 2.49. Ivanhoe Energy Inc. (Ivanhoe) is an independent international heavy oil development and production company. Ivanhoe’s core operations are in Canada, Ecuador, China and Mongolia, with business development opportunities worldwide. Ivanhoe’s wholly owned subsidiary, Sunwing Energy Ltd. (Sunwing) is focused on a natural gas exploration project (the Zitong Block) in Sichuan Province of China.
Why Should Investors Buy IVAN After the Recent Fall? Just Go Here and Find Out
VIVUS, Inc (NASDAQ:VVUS) the stock decreased -0.77% and finished the session at $9.08. Traded with volume of 1.30 million shares in the prior session and the average volume of the stock remained 1.58 million shares. The beta of the stock remained 1.31. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese),
Will VVUS Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)